Literature DB >> 23650205

Functional defect of peripheral neutrophils in mice with induced deletion of CXCR2.

Liping Liu1, MeiZhang Li, Lisa C Spangler, Charles Spear, Mike Veenstra, Lindsey Darnall, Cathleen Chang, Anne C Cotleur, Richard M Ransohoff.   

Abstract

Type 2 CXC chemokine receptor CXCR2 plays roles in development, tumorigenesis, and inflammation. CXCR2 also promotes demyelination and decreases remyelination by actions toward hematopoietic cells and nonhematopoietic cells. Germline CXCR2 deficient (Cxcr2(-/-) ) mice reported in 1994 revealed the complexity of CXCR2 function and its differential expression in varied cell-types. Here, we describe Cxcr2(fl/fl) mice for which the targeting construct was generated by recombineering based on homologous recombination in E. coli. Without recombination Cxcr2(fl/fl) mice have CXCR2 expression on neutrophils in peripheral blood, bone marrow and spleen. Cxcr2(fl/fl) mice were crossed to Mx-Cre mice in which Cre recombinase is induced by Type I interferons, elicited by injection with polyinosinic-polycytidylic acid (poly(I:C)). CXCR2-deficient neutrophils were observed in poly(I:C) treated Cxcr2(fl/fl) ::Mx-Cre(+) (Cxcr2-CKO) mice, but not in poly(I:C) treated Cxcr2(f//+) ::Mx-Cre(+) mice. CXCR2 deletion was mainly observed peripherally but not in the CNS. Cxcr2-CKO mice showed impaired neutrophil migration in sterile peritonitis. Cxcr2-CKO mice reported here will provide a genetic reagent to dissect roles of CXCR2 in the neutrophil granulocyte lineage. Furthermore Cxcr2(fl/fl) mice will provide useful genetic models to evaluate CXCR2 function in varied cell populations.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CXCR2; chemokine; chemokine receptor; conditional KO mice; neutrophil

Mesh:

Substances:

Year:  2013        PMID: 23650205      PMCID: PMC3753089          DOI: 10.1002/dvg.22401

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  24 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Delayed wound healing in CXCR2 knockout mice.

Authors:  R M Devalaraja; L B Nanney; J Du; Q Qian; Y Yu; M N Devalaraja; A Richmond
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

3.  The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration.

Authors:  Hui-Hsin Tsai; Emma Frost; Vivien To; Shenandoah Robinson; Charles Ffrench-Constant; Robert Geertman; Richard M Ransohoff; Robert H Miller
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

4.  Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.

Authors:  LiPing Liu; Lindsey Darnall; Taofang Hu; Karen Choi; Thomas E Lane; Richard M Ransohoff
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

5.  A CXCL1 paracrine network links cancer chemoresistance and metastasis.

Authors:  Swarnali Acharyya; Thordur Oskarsson; Sakari Vanharanta; Srinivas Malladi; Juliet Kim; Patrick G Morris; Katia Manova-Todorova; Margaret Leversha; Nancy Hogg; Venkatraman E Seshan; Larry Norton; Edi Brogi; Joan Massagué
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

6.  CXC receptor-2 knockout genotype increases X-linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicity.

Authors:  Bin Hu; Lisa M Colletti
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

7.  G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands.

Authors:  Anja Köhler; Katia De Filippo; Mike Hasenberg; Cindy van den Brandt; Emma Nye; Martin P Hosking; Thomas E Lane; Linda Männ; Richard M Ransohoff; Anja E Hauser; Oliver Winter; Burkhart Schraven; Hartmut Geiger; Nancy Hogg; Matthias Gunzer
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

8.  A highly efficient recombineering-based method for generating conditional knockout mutations.

Authors:  Pentao Liu; Nancy A Jenkins; Neal G Copeland
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

9.  Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.

Authors:  Thomas Jamieson; Mairi Clarke; Colin W Steele; Michael S Samuel; Jens Neumann; Andreas Jung; David Huels; Michael F Olson; Sudipto Das; Robert J B Nibbs; Owen J Sansom
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

10.  Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter.

Authors:  H Hug; M Costas; P Staeheli; M Aebi; C Weissmann
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

View more
  14 in total

1.  An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage.

Authors:  Makoto Inoue; Po-Han Chen; Stephen Siecinski; Qi-Jing Li; Chunlei Liu; Lawrence Steinman; Simon G Gregory; Eric Benner; Mari L Shinohara
Journal:  Nat Neurosci       Date:  2016-11-07       Impact factor: 24.884

Review 2.  Mononuclear phagocyte-mediated antifungal immunity: the role of chemotactic receptors and ligands.

Authors:  Muthulekha Swamydas; Timothy J Break; Michail S Lionakis
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

3.  Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.

Authors:  Bhawna Sharma; Kalyan C Nannuru; Michelle L Varney; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2014-12-16       Impact factor: 5.150

4.  Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.

Authors:  Brett S Marro; Dominic D Skinner; Yuting Cheng; Jonathan J Grist; Laura L Dickey; Emily Eckman; Colleen Stone; Liping Liu; Richard M Ransohoff; Thomas E Lane
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 5.  The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs.

Authors:  Jan Korbecki; Iwona Szatkowska; Patrycja Kupnicka; Wojciech Żwierełło; Katarzyna Barczak; Iwona Poziomkowska-Gęsicka; Jerzy Wójcik; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

6.  Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes.

Authors:  Karine Haurogné; Marija Pavlovic; Hélène Rogniaux; Jean-Marie Bach; Blandine Lieubeau
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

7.  CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses.

Authors:  Douglas P Dyer; Kenneth Pallas; Laura Medina-Ruiz; Fabian Schuette; Gillian J Wilson; Gerard J Graham
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

8.  Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.

Authors:  Jinming Yang; Chi Yan; Anna E Vilgelm; Sheau-Chiann Chen; Gregory D Ayers; Christopher A Johnson; Ann Richmond
Journal:  Cancer Immunol Res       Date:  2020-11-11       Impact factor: 12.020

9.  Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.

Authors:  LiPing Liu; Lisa C Spangler; Briana Prager; Bryan Benson; BingQing Hu; Samuel Shi; Anna Love; CunJin Zhang; Meigen Yu; Anne C Cotleur; Richard M Ransohoff
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-19

10.  Hydrodynamic Gene Delivery of CC Chemokine Binding Fc Fusion Proteins to Target Acute Vascular Inflammation In Vivo.

Authors:  Eileen McNeill; Asif J Iqbal; Gemma E White; Jyoti Patel; David R Greaves; Keith M Channon
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.